Radiofrekvensablation reducerer risikoen ved dysplastisk Barretts oesophagus

TY - JOUR

T1 - Radiofrekvensablation reducerer risikoen ved dysplastisk Barretts oesophagus

AU - Achiam, Michael

AU - Holm, Jakob

AU - Svendsen, Lars Bo

PY - 2014/1/6

Y1 - 2014/1/6

N2 - Barrett's esophagus (BE) with dysplasia is generally accepted as the precursor to oesophageal cancer. Thus, methods to eradicate BE and dysplasia have been evaluated. Recently, radiofrequency ablation (RFA) has shown promising results with few adverse effects. The studies concerning RFA are, however, small and heterogeneous. Only six studies have included more than 100 patients and only one is a prospective randomized trial. The purpose of this article is to describe the treatment of BE and especially the indications and challenges of RFA, including complications, buried glands and recurrence.

AB - Barrett's esophagus (BE) with dysplasia is generally accepted as the precursor to oesophageal cancer. Thus, methods to eradicate BE and dysplasia have been evaluated. Recently, radiofrequency ablation (RFA) has shown promising results with few adverse effects. The studies concerning RFA are, however, small and heterogeneous. Only six studies have included more than 100 patients and only one is a prospective randomized trial. The purpose of this article is to describe the treatment of BE and especially the indications and challenges of RFA, including complications, buried glands and recurrence.

M3 - Tidsskriftartikel

C2 - 25346313

SN - 0041-5782

VL - 176

SP - 1288

EP - 1291

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 14

M1 - V06130409

ER -